• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Nexus Pharmaceuticals Inc. Issues Voluntary Nationwide Recall of Benztropine
Mesylate Injection, USP 2 mg/2 mL (1 mg/mL), in 2 mL Single Dose Vials

Benztropine Mesylate Injection 

Return to Firm Press